Skip to main content

Allergy Skin

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Covalon Technologies
Covalon TechnologiesON - Mississauga
1 program
ColActivePlus Collagen Matrix DressingN/A1 trial
Active Trials
NCT06271993Completed27Est. Feb 2024

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Covalon TechnologiesColActivePlus Collagen Matrix Dressing

Clinical Trials (1)

Total enrollment: 27 patients across 1 trials

NCT06271993Covalon TechnologiesColActivePlus Collagen Matrix Dressing

SPT for Sensitization of Collagen Dressing

Start: Feb 2024Est. completion: Feb 202427 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.